betamethasone-17,21-dipropionate has been researched along with Fungal Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlisle, R; Ferrel, M; Flint, ND; Hopkins, ZH; Rhoads, JLW; Secrest, AM | 1 |
| Feldman, SR; Fleischer, AB; Shaffer, MP | 1 |
2 other study(ies) available for betamethasone-17,21-dipropionate and Fungal Diseases
| Article | Year |
|---|---|
The continued inappropriate use and overuse of combination topical clotrimazole-betamethasone.
Topics: Adolescent; Adult; Antifungal Agents; Betamethasone; Child; Clotrimazole; Drug Combinations; Female; Glucocorticoids; Humans; Logistic Models; Male; Mycoses; Prescription Drug Overuse; Retrospective Studies | 2021 |
Use of clotrimazole/betamethasone diproprionate by family physicians.
Topics: Administration, Topical; Adult; Age Factors; Ambulatory Care; Anti-Inflammatory Agents; Antifungal Agents; Betamethasone; Candidiasis; Child, Preschool; Clotrimazole; Cost Savings; Demography; Dermatology; Drug Combinations; Drug Costs; Drug Prescriptions; Drug Utilization; Family Practice; Female; Glucocorticoids; Humans; Male; Middle Aged; Mycoses; Pediatrics; United States | 2000 |